Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Common Stock Shares Outstanding of 1.07 billion shares for the year ending 2025.
- ELITE PHARMACEUTICALS INC /NV/ showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ELITE PHARMACEUTICALS INC /NV/'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), ELITE PHARMACEUTICALS INC /NV/'s Common Stock Shares Outstanding has grown by 491.7%.
- Historical annual values: Fiscal year 2025: 1.07 billion shares | Fiscal year 2024: 1.07 billion shares | Fiscal year 2023: 1.01 billion shares | Fiscal year 2022: 1.01 billion shares | Fiscal year 2021: 1.01 billion shares | Fiscal year 2020: 840.40 million shares | Fiscal year 2019: 824.85 million shares | Fiscal year 2018: 802.53 million shares | Fiscal year 2017: 927.93 million shares | Fiscal year 2016: 711.44 million shares | Fiscal year 2015: 631.06 million shares | Fiscal year 2014: 560.14 million shares | Fiscal year 2013: 374.39 million shares | Fiscal year 2012: 331.65 million shares | Fiscal year 2011: 180.55 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: